SCHEMBL28690124

SCHEMBL28690124

O=C(Nc1ncc(-c2ccco2)[nH]1)c1cc(-c2cccc(Cl)c2)nc2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.58
▸ CACNA1B Q00975 2/20 0.56
▸ APBA1 Q02410 2/20 0.56
▸ MEN1 O00255 4/20 0.54
▸ KMT2A Q03164 4/20 0.54
▸ NPC1 O15118 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ GFER P55789 1/20 0.54
▸ MAPT P10636 4/20 0.53
▸ STAT3 P40763 3/20 0.53
▸ CA12 O43570 1/20 0.52
▸ CA1 P00915 1/20 0.52
▸ CA2 P00918 1/20 0.52
▸ CA9 Q16790 1/20 0.52
▸ KDM4E B2RXH2 3/20 0.50
▸ HPGD P15428 2/20 0.50
▸ TACR3 P29371 1/20 0.50
▸ ALOX15 P16050 1/20 0.50
▸ TSHR P16473 1/20 0.50
▸ HSD17B10 Q99714 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28681436 0.92 STAT3 (0.61) ALDH1A1CACNA1BAPBA1MEN1KMT2A
SCHEMBL28699068 0.91 STAT3 (0.54) ALDH1A1CACNA1BAPBA1MEN1KMT2A
SCHEMBL28699093 0.88 CTDSP1 (0.62) ALDH1A1CACNA1BAPBA1MEN1KMT2A
SCHEMBL28931754 0.88 MEN1 (0.59) ALDH1A1CACNA1BAPBA1MEN1KMT2A
SCHEMBL28696288 0.87 CACNA1B (0.53) ALDH1A1CACNA1BAPBA1MEN1KMT2A
SCHEMBL28693080 0.87 STAT3 (0.64) ALDH1A1CACNA1BAPBA1MEN1KMT2A
SCHEMBL28695985 0.87 STAT3 (0.55) ALDH1A1CACNA1BAPBA1MEN1KMT2A
SCHEMBL28697036 0.87 MAPT (0.55) ALDH1A1CACNA1BAPBA1MEN1KMT2A
SCHEMBL28683191 0.86 MEN1 (0.54) ALDH1A1CACNA1BAPBA1MEN1KMT2A
SCHEMBL28673399 0.86 MEN1 (0.58) ALDH1A1CACNA1BAPBA1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113747920-A Immune checkpoint inhibitor combination therapy using quinoline carboxamide derivatives 株式会社益力多本社 2021-12-03 — — CN disclosed
CN-112703001-A Combination cancer therapy using quinoline carboxamide derivatives 株式会社益力多本社 2021-04-23 — — CN disclosed
Send feedback